Google
Trusted Resources: Community Center
Online groups, photo galleries and blogs
Protein Folding 09: Sickle Cell Disease
Sickle cell disease affects ~70,000 to 100,000 people in the United States, and ~10 million worldwide. The disease was first described by James B. Herrick [Herrick 1910]. The molecular basis was partly elucidated by Linus Pauling and Ibert C. Wells [Pauling 1949], and the exact causal amino acid substitution (E6V) was later identified by V.M. Ingram [Ingram 1956]. This missense variant causes hemoglobin to form long polymers which deform red blood cells into a “sickle” shape.
+myBinderRelated Content
-
The Hazards of Hazardous Drug Labeling: Time to Revisit Hydroxyurea?Despite benefits in reducing pain crises...
-
Management of Sickle Cell Disease SymposiumThe Management of Sickle Cell Symposium ...
-
Assessing Disease Knowledge and Self-Management in Youth With Sickle Cell Disease Prior to TransitionIntroduction: Transition of medical car...
-
Coretta Jenerette, PhD, RNCoretta M. Jenerette, PhD, RN, CNE, earn...
-
U.S. Government Awards Missouri Researcher $4.3 Million to Study Sickle Cell in Teens, AdultsThe National Institutes of Health (NIH) ...
-
Cayenne Wellness Center’s 15th Annual Sickle Cell Disease Educational SummitCayenne Wellness Center’s Annual Sickl...
-
New Research Suggests SANGUINATE™ Reduces the Number of Sickled Red Blood Cells in Patients with Vaso-Occlusive Cr...SANGUINATE™, the only investigational ...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
